H
0.411
-0.02 (-5.60%)
| Penutupan Terdahulu | 0.435 |
| Buka | 0.461 |
| Jumlah Dagangan | 638,411 |
| Purata Dagangan (3B) | 6,482,756 |
| Modal Pasaran | 114,175,024 |
| Harga / Pendapatan (P/E Ke hadapan) | 35.84 |
| Harga / Jualan (P/S) | 51.64 |
| Harga / Buku (P/B) | 5.01 |
| Julat 52 Minggu | |
| Tarikh Pendapatan | 12 Nov 2026 |
| Margin Operasi (TTM) | -4,484.33% |
| EPS Cair (TTM) | -0.690 |
| Jumlah Hutang/Ekuiti (D/E MRQ) | 228.93% |
| Nisbah Semasa (MRQ) | 3.68 |
| Aliran Tunai Operasi (OCF TTM) | -99.38 M |
| Aliran Tunai Bebas Leveraj (LFCF TTM) | -67.40 M |
| Pulangan Atas Aset (ROA TTM) | -42.82% |
| Pulangan Atas Ekuiti (ROE TTM) | -249.75% |
Arah Aliran Pasaran
| Jangka Pendek | Jangka Sederhana | ||
| Industri | Biotechnology (US) | Bercampur | Menaik |
| Biotechnology (Global) | Bercampur | Menaik | |
| Stok | Humacyte, Inc. | Bercampur | Menaik |
AISkor Stockmoo
0.5
| Konsensus Penganalisis | NA |
| Aktiviti Orang Dalam | NA |
| Volatiliti Harga | 0.5 |
| Purata Bergerak Teknikal | 3.5 |
| Osilator Teknikal | -2.5 |
| Penilaian Relatif | NA |
| Kesihatan Kewangan | NA |
| AI Insight | NA |
| Purata | 0.50 |
|
Humacyte Inc is developing a commercial-stage biotechnology platform to deliver universally implantable bioengineered human tissues and organs designed to improve the lives of patients and transform the practice of medicine. It develops and manufactures acellular tissues to treat a wide range of diseases, injuries, and chronic conditions. Company's pipeline includes Vascular Trauma, PAD, Dailysis, Acellular Tissue Engineered Vessels, Organ Systems, Advanced Tissue Constructs. |
|
| Sektor | Healthcare |
| Industri | Biotechnology |
| Gaya Pelaburan | Small Growth |
| % Dimiliki oleh Orang Dalam | 20.16% |
| % Dimiliki oleh Institusi | 40.20% |
Pemilikan
| Nama | Tarikh | Syer Dipegang |
|---|---|---|
| Antipodes Partners Ltd | 30 Jun 2026 | 10,103,647 |
| Great Point Partners I Lp | 30 Jun 2026 | 3,750,000 |
Tiada data dalam julat masa ini.
Tiada data dalam julat masa ini.
AI Analisis Teknikal
Buka tab Teknikal untuk menjana analisis terkini.
Portfolio
| Keuntungan Nyata | - |
| Keuntungan Tidak Nyata | - |
| Dividen Diterima 2026 | - |
| Jumlah Untung | - |
| Pulangan Purata | - |
| Kuantiti (Beli) | - |
| Purata Harga (Beli) | - |
| Kuantiti (Jual) | - |
| Purata Harga (Jual) | - |